ArticleEBioMedicine2020

A new avenue for treating Parkinson's disease targeted at aggrephagy modulation and neuroinflammation: Insights from in vitro and animal studies.

Maria A TikhonovaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.